Physician profile
Sunil Dogra
NPI 1225089402
$1,883.79
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,214 · 2020: $356 · 2021: $314.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $359.34 | 2019-2021 | |
| Amgen INC. | $342.73 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $252.61 | 2019-2021 | |
| Pfizer INC. | $185.47 | 2019-2021 | |
| Daiichi Sankyo INC. | $125.50 | 2019 | |
| Scilex Pharmaceuticals INC. | $124.81 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $111.05 | 2019-2021 | |
| Upsher-Smith Laboratories LLC | $102.97 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $77.70 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $38.09 | 2019 | |
| Redhill Biopharma INC. | $34.22 | 2021 | |
| Biodelivery Sciences International, INC. | $23.75 | 2019-2021 | |
| Forte Bio-Pharma LLC | $22.00 | 2019-2020 | |
| Mdd US Operations, LLC | $18.37 | 2019 | |
| Promius Pharma LLC | $15.92 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $13.81 | 2020 | |
| Assertio Therapeutics, INC. | $13.61 | 2020 | |
| Sentynl Therapeutics, INC. | $11.11 | 2019 | |
| Stimwave Technologies Incorporated | $10.73 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Dogra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.